By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Plozasiran Update On January 17, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for plozasiran for the treatment of familial chylomycronemia syndrome (FCS), with a Prescription Drug User Fee Act … Read more
The world was hit by so many floods and landslides in 2024 that it triggered the aid sector’s first multi-disaster insurance pay-out, the Red Cross told Reuters, signaling both the scale of the problem and the need for new financing solutions. The International Federation of the Red Cross and Red Crescent Societies (IFRC) said such … Read more
Brown, Goldstein & Levy partner Greg Care was named to the 2025 Lawdragon 500 Leading Litigators in America Guide in both the Health Care Provider Regulatory and Commercial Litigation categories, marking his third year in a row being highlighted on the list. As someone who specializes in resident physician disciplinary issues and employee rights, Greg … Read more
By M. Marin NASDAQ:WINT Lead Drug Candidates, New Phase 2b Clinical Trial Data, Multiple Programs Focus on Unmet Needs In Cardiogenic Shock & AHF Pennsylvania-based Windtree Therapeutics, Inc. (NASDAQ:WINT) is a biopharmaceutical company developing therapies for a range of cardiovascular and oncology treatments characterized by significant unmet need. The company’s lead indication area is cardiogenic … Read more
Are you operating a brick-and-mortar or service-based business with a physical presence in different areas? Then, you should have a search engine optimization (SEO) strategy for multiple locations. A digital presence in each of the areas you serve boosts your online and physical traffic. Google reports that 60% of smartphone users will contact a business … Read more
